close 73% jaeinvestorite kontodest jääb selle teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. CFD-d on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti. 73% jaeinvestorite kontodest jääb selle teenusepakkuja juures CFD-dega kauplemisel kahjumisse. Palume teil kaaluda, kas CFD-de toimimine on teile arusaadav ja kas te olete valmis võtma riski, mis suure tõenäosusega on kahjumlik.
Change languageEesti
Ülevaade

LLY

926.07

+0.34%↑

JNJ

186.46

-0.33%↓

UNH

329.46

+0.06%↑

NVS

126.06

+0.47%↑

ABT

123.82

-1.94%↓

LLY

926.07

+0.34%↑

JNJ

186.46

-0.33%↓

UNH

329.46

+0.06%↑

NVS

126.06

+0.47%↑

ABT

123.82

-1.94%↓

LLY

926.07

+0.34%↑

JNJ

186.46

-0.33%↓

UNH

329.46

+0.06%↑

NVS

126.06

+0.47%↑

ABT

123.82

-1.94%↓

LLY

926.07

+0.34%↑

JNJ

186.46

-0.33%↓

UNH

329.46

+0.06%↑

NVS

126.06

+0.47%↑

ABT

123.82

-1.94%↓

LLY

926.07

+0.34%↑

JNJ

186.46

-0.33%↓

UNH

329.46

+0.06%↑

NVS

126.06

+0.47%↑

ABT

123.82

-1.94%↓

Kodu・Aktsiate loetelu・WaVe Life Sciences Ltd
Search

WaVe Life Sciences Ltd

Suletud

8.04 0.5

Tugev "osta" hinnang

Hinna uuendus 5. nov 2025, 20:59 UTC

OstaMüü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

7.71

Max

8.06

Põhinäitajad

By Trading Economics

Sissetulek

-3.6M

-50M

Müük

-476K

8.7M

Kasumimarginaal

-580.17

Töötajad

287

EBITDA

-2.9M

-51M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+156.55% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

10. nov 2025

Turustatistika

By TradingEconomics

Turukapital

51M

1.3B

Eelmine avamishind

7.54

Eelmine sulgemishind

8.04

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

6.35 / 6.555 Toetus ja vastupanu

WaVe Life Sciences Ltd Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

5. nov 2025, 23:51 UTC

Tulu

CoreCivic Cuts Fiscal Year Guidance Amid Efforts to Launch New Detention Facilities

DJ

Loe

5. nov 2025, 23:10 UTC

Tulu

DBS Third Quarter Net Dips 2.0%

DJ

Loe

5. nov 2025, 22:55 UTC

Tulu

Arm Holdings 2Q Profit Climbs on Record Demand

DJ

Loe

5. nov 2025, 22:23 UTC

Tulu

NAB's Annual Profit Falls 2.9% Amid Higher Costs, Credit Impairments -- Update

DJ

Loe

5. nov 2025, 23:52 UTC

Tulu

United Overseas Bank 3Q Net Interest Income S$2.265B Vs. $2.46B >U11.SG

DJ

Loe

5. nov 2025, 23:49 UTC

Tulu

United Overseas Bank 3Q Total Income S$3.40B Vs. S$3.83B >U11.SG

DJ

Loe

5. nov 2025, 23:49 UTC

Tulu

United Overseas Bank 3Q Net S$443M Vs. Net S$1.61B >U11.SG

DJ

Loe

5. nov 2025, 23:45 UTC

Market Talk

Nikkei May Rise on Weaker Yen, U.S. Tech Rebound -- Market Talk

DJ

Loe

5. nov 2025, 23:42 UTC

Market Talk

Gold Edges Lower Amid Reduced Odds of Fed Rate-Cut -- Market Talk

DJ

Loe

5. nov 2025, 23:12 UTC

Tulu

Nutrien 3Q Adj EPS 97c >NTR.T

DJ

Loe

5. nov 2025, 23:11 UTC

Tulu

Nutrien: Initiating Review of Strategic Alternatives for Phosphate Business >NTR.T

DJ

Loe

5. nov 2025, 23:10 UTC

Tulu

Nutrien 3Q Sales $6.01B >NTR.T

DJ

Loe

5. nov 2025, 23:10 UTC

Market Talk
Tulu

AppLovin Says Conversion Rate Is Biggest Growth Lever -- Market Talk

DJ

Loe

5. nov 2025, 23:10 UTC

Tulu

Nutrien 3Q EPS 96c >NTR.T

DJ

Loe

5. nov 2025, 23:04 UTC

Tulu

Qualcomm Stock Slides After Earnings Beat -- Barrons.com

DJ

Loe

5. nov 2025, 23:03 UTC

Market Talk

Macklem: Canada's Regulatory Overlap Turns Off Foreign Investors -- Market Talk

DJ

Loe

5. nov 2025, 22:55 UTC

Market Talk

Macklem Says Inflation and Productivity Are Intertwined -- Market Talk

DJ

Loe

5. nov 2025, 22:55 UTC

Tulu

AppLovin Reports Strong Earnings. The Stock Is Up. -- Barrons.com

DJ

Loe

5. nov 2025, 22:51 UTC

Tulu

DBS 3Q Total Income S$5.93B, Up 3% on Year >D05.SG

DJ

Loe

5. nov 2025, 22:50 UTC

Tulu

DBS 3Q Net S$2.95B, Down 2.0% on Year >D05.SG

DJ

Loe

5. nov 2025, 22:44 UTC

Omandamised, ülevõtmised, äriostud

Pfizer Preps Improved Offer in Metsera Bidding War -- Update

DJ

Loe

5. nov 2025, 22:43 UTC

Market Talk
Tulu

NAB's Flat Dividend Disappoints Bears at Jarden -- Market Talk

DJ

Loe

5. nov 2025, 22:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Loe

5. nov 2025, 22:36 UTC

Market Talk

Macklem Warns Structural Adjustment Means Slow Canadian Growth -- Market Talk

DJ

Loe

5. nov 2025, 22:20 UTC

Market Talk

Bank of Canada Says Budget Plan Identifies Economy's Biggest Weakness -- Market Talk

DJ

Loe

5. nov 2025, 22:12 UTC

Omandamised, ülevõtmised, äriostud

Pfizer: Will Take Action to Preserve Rights Under Previously-Signed Agreement >PFE

DJ

Loe

5. nov 2025, 22:11 UTC

Omandamised, ülevõtmised, äriostud

Pfizer: Confident in Merits of Claims, Belief Metsera Has Acted in Breach of Contractual Obligations >PFE

DJ

Loe

5. nov 2025, 22:11 UTC

Omandamised, ülevõtmised, äriostud

Pfizer Responds to Delaware Chancery Court Ruling

DJ

Loe

5. nov 2025, 22:01 UTC

Tulu

Great-West Lifeco 3Q Net C$1.16B >GWO.T

DJ

Loe

5. nov 2025, 22:01 UTC

Tulu

Great-West Lifeco 3Q Adj EPS C$1.33 >GWO.T

DJ

Loe

Võrdlus sarnastega

Hinnamuutus

WaVe Life Sciences Ltd Prognoos

Hinnasiht

By TipRanks

156.55% tõus

12 kuu keskmine prognoos

Keskmine 20.55 USD  156.55%

Kõrge 36 USD

Madal 12 USD

Põhineb 11 Wall Streeti analüütiku instrumendi WaVe Life Sciences Ltd 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

11 ratings

11

Osta

0

Hoia

0

Müü

Põhineb 11 analüütiku instrumendi WaVe Life Sciences Ltd aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

6.35 / 6.555Toetus ja vastupanu

Lühikene perspektiiv

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Keskpikk perspektiiv

Bearish Evidence

All events are bearish.

Pikk perspektiiv

Bearish Evidence

Recent bearish events outweigh bullish events.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Muud aktsiad sektorist

LLY

Eli Lilly and Co.

926.07

↑ +0.34%

JNJ

Johnson and Johnson

186.46

↓-0.33%

UNH

UnitedHealth Group Inc

329.46

↑ +0.06%

NVS

Novartis AG

126.06

↑ +0.47%

ABT

Abbott Laboratories

123.82

↓-1.94%
help-icon Live chat